Capital Allocation

Creator commerce firm Amaze Holdings cancels a special meeting on a crucial stock dilution vote, raising questions about shareholder support and strategy.

Amidst economic headwinds, JD Power projects 16.3M vehicle sales for 2026 and launches its new 'Power Platform' to help the industry navigate disruption.

National Debt Relief triples its sponsorship of Denny Hamlin's car, betting big on NASCAR's loyal fanbase to tackle the growing issue of U.S. household debt.

An accounting software firm has launched a video series exposing MLB's financial flaws. Can their 10-point plan prevent the next devastating lockout?

As PHINIA preps for its NYSE Investor Day, it plans to prove its value by balancing legacy engine tech with bold investments in a lower-carbon future.

S&P Global unveils 'Mobility Global' for its auto data spin-off, aiming to dominate the $30B market despite a sharp one-day drop in its stock price.

Estrella Immunopharma unveils promising Phase 1 data for its next-gen T-cell therapy, but can it overcome a crowded market and its own financial hurdles?

Two specialized firms are joining forces, creating BlackBirchSCR to offer a new, unified model for capital raising and strategic communications.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

After a brutal winter storm cut Bitcoin production, Cango Inc. is selling its crypto reserves to fund a strategic expansion into the booming AI market.

Powersports giant Massimo Group's stock plummets after announcing a bold but risky plan to acquire an AI firm and enter the health robotics market.

The Swedish industrial giant posted strong sales and improved margins for 2025, but a significant dip in new orders has investors watching the future closely.

Pharming Group projects strong 2026 growth, fueling ambitious clinical programs for rare immunodeficiencies and mitochondrial diseases.

The auto supplier's 2025 results show a profitable balance between legacy tech and EV innovation, fueled by post-acquisition operational discipline.

Morningstar's $365M CRSP acquisition and extended Vanguard pact positions it to challenge index titans, promising a new era for low-cost investing.

Facing a 'going concern' warning, PMAX lands a $17M PIPE deal, using most of it to buy back shares from its parent company. What's the strategy?

Devonian appoints veteran CFO Dennis Turpin and corrects stock options, signaling a strategic shift as it aims to overcome financial hurdles and advance its pipeline.

With home health aide costs nearing $78,000 annually, families face a financial maze. Learn key strategies for creating a realistic budget for senior care.

As the surety market faces new challenges, Rosenberg & Parker brings in Michael Bogansky to fortify its financial strategy for a new era of expansion.

Intuit's QuickBooks will exclusively integrate Affirm's BNPL, letting SMBs get paid upfront while customers pay over time to fix cash flow issues.